Getting the shampoo treatment in Times Square | Andrew Dudum
Business

A $200M valuation, TV commercials, and billboards: A closer (critical) look at how Hims is fast-tracking the modern luxury playbook.

The men’s wellness upstart is (wisely) fast-tracking the DNVB playbook, but we’re worried whether a $200M valuation is justified for a consumer-facing brand that’s only four months into business.

READ MORE →
Blumenthal drops gold on stage with STORY's Rachel Shechtman | National Retail Federation
Business

Warby Parker’s Neil Blumenthal articulates modern luxury thinking perfectly in this panel talk.

Warby’s cofounder echos a major point we’ve been making over texts, calls, emails, and dinners with friends and readers for some time now: When thinking about modern luxury today, product alone isn’t enough. It’s the package that really matters.

READ MORE →
Gilboa and Blumenthal | Warby Parker
Business

Neil Blumenthal and Dave Gilboa: “Warby’s next step could be telemedicine, and we want to be a pioneer.”

Having already conquered branding, retail, and product, Warby Parker is eyeing new frontiers as it gears up for international expansion and an inevitable IPO. One big opportunity for growth: telemedicine.

READ MORE →
Neil Blumenthal and Dave Gilboa side by side | Photo credit: Bloomberg
Business

Warby Parker’s new $15M ‘Optical Lab’: Smart offense or reactive defense?

This goes beyond just making lenses in-house, getting sweet tax breaks, and rubbing shoulders with elected officials.

READ MORE →
It's an eyewear jungle out there | Photo credit: David Kind
Business

David Kind and the Eyewear Goliath(s).

With Luxottica and Warby Parker both dominating eyewear, David Kind is carving out a high-end moat in a category that’s ultra competitive at the low end.

READ MORE →